The Importance of Genetic Testing for Familial Hypercholesterolemia: A Pediatric Pilot Study

Area of Science:

• Cardiology
• Genetics
• Metabolic Disorders

Background:

• Familial hypercholesterolemia (FH) is a prevalent, underdiagnosed genetic disorder.
• FH significantly elevates the risk of premature cardiovascular events.
• Early detection and intervention in childhood are vital for preventing heart attacks and strokes.

Purpose of the Study:

• To evaluate the impact of genetic testing in diagnosing familial hypercholesterolemia.
• To assess the effectiveness of lifestyle and diet recommendations in FH patients.
• To determine the necessity of genetic confirmation for guiding FH treatment strategies.

Main Methods:

• An interventional study involving 10 patients with prior genetic testing for FH.
• Patients received one year of lifestyle and diet recommendations.
• Lipid panels were reevaluated after the intervention period.

Main Results:

• Patients without FH showed significant lipid panel improvements with lifestyle changes alone.
• LDL-cholesterol decreased by 18.5% in genetically negative FH individuals.
• Patients with confirmed FH did not achieve significant LDL-cholesterol reduction without medication.

Conclusions:

• Genetic testing for FH is essential for accurate diagnosis and treatment planning.
• Relying solely on screening algorithms without genetic confirmation can be insufficient.
• Genetic testing guides appropriate therapeutic interventions, distinguishing FH from other hyperlipidemias.